To test whether transcriptional silencing of one Chr21 can prevent this known DS cell phenotype, (Chiang et al. 2018) tested this for hematopoiesis and affirmed that induced XIST expression during in vitro differentiation of iPSCs indeed corrects this known hematopoietic pathogenesis. This evidence concerns the gene XIST and Dravet syndrome.